This systematic review and meta-analysis show that interventions aimed at increasing gut-derived metabolites—especially sodium butyrate and multi-strain synbiotics—yield measurable improvements in key hormonal (testosterone, LH/FSH ratio) and metabolic (fasting insulin, HOMA-IR, HDL-C) outcomes in women with PCOS. The gene discussed is BRD2; the disease is polycystic ovary syndrome.